Company intelligence / Profile preview

Forrest Innovations

Ownership: Private
Employees: ~5
Development stage: Commercial

Overview

Forrest Innovations has demonstrated groundbreaking success with its NVC technology in Ortigueira, Brazil. After implementation, the city saw a reduction of up to 99% in mosquito populations and a corresponding drop of approximately 97% in dengue cases compared to neighboring cities over the same period. These results were published by LANCET Regional Health Americas. The company’s approach has been validated at scale with strong real-world impact.

Therapeutic areas: Infectious Diseases
Modalities: Biological vector control (sterile insect technique)
Industry: Non-Drug Biotech

Partnerships

Collaborations with local governments/public health authorities in Brazil for field deployment.

Beyond the preview

Go deeper on Forrest Innovations.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Forrest Innovations.

Explore the full profile